Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady State

Conditions

• Healthy Volunteers

Interventions

• DRUG: Dabigatran etexilate
• DRUG: Idarucizumab

Sponsor

Boehringer Ingelheim